Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Nasopharyngeal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07388758
What this trial is testing

Scipibaimab Combined With Tislelizumab in Patients With First-Line Treatment-Failed Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University 37
Testing effectiveness (Phase 2)Ended earlyNCT01267240
What this trial is testing

Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

Who this might be right for
Paranasal Sinus Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+14 more
National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Study completedNCT00103259
What this trial is testing

Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the LarynxRecurrent Squamous Cell Carcinoma of the Lip and Oral Cavity+22 more
National Cancer Institute (NCI) 71
Very early researchUnknownNCT05616468
What this trial is testing

BGT007 Cell Treatment of Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
The Affiliated Hospital of Xuzhou Medical University 23
Testing effectiveness (Phase 2)Study completedNCT00055913
What this trial is testing

Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Recurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the LarynxRecurrent Squamous Cell Carcinoma of the Lip and Oral Cavity+10 more
National Cancer Institute (NCI) 58
Large-scale testing (Phase 3)UnknownNCT02633176
What this trial is testing

Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 120
Testing effectiveness (Phase 2)UnknownNCT05385926
What this trial is testing

Combining RT With Immunotherapy and Chemotherapy in Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Metastatic Nasopharyngeal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 34
Early research (Phase 1)Looking for participantsNCT05194982
What this trial is testing

BL-B01D1 in Patients With Locally Advanced or Metastatic Solid Tumor

Who this might be right for
Locally Advanced or Metastatic Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 570
Testing effectiveness (Phase 2)Study completedNCT00019331
What this trial is testing

Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors

Who this might be right for
Colorectal CancerEndometrial CancerHead and Neck Cancer+6 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT02789189
What this trial is testing

Nedaplatin Combined With Gemcitabine in the Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma : a Single Arm and Phase Ⅱ Clinical Trail

Who this might be right for
Recurrent and Metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Large-scale testing (Phase 3)Active Not RecruitingNCT06629597
What this trial is testing

A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma (TAISHAN-301)

Who this might be right for
Nasopharyngeal Carcinoma
MediLink Therapeutics (Suzhou) Co., Ltd. 400
Early research (Phase 1)Study completedNCT00030498
What this trial is testing

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more
National Cancer Institute (NCI) 75
Testing effectiveness (Phase 2)Study completedNCT03422536
What this trial is testing

Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Basaloid CarcinomaRecurrent Head and Neck Squamous Cell CarcinomaRecurrent Oropharyngeal Squamous Cell Carcinoma+21 more
University of Arizona 78
Testing effectiveness (Phase 2)Study completedNCT00101348
What this trial is testing

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more
National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)Study completedNCT00003264
What this trial is testing

Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Fox Chase Cancer Center 22
Not applicableActive Not RecruitingNCT06762470
What this trial is testing

Prognostic Value of CD4/CD8 Ratio in Patients with Nasopharyngeal Carcinoma

Who this might be right for
Histopathological Diagnosis of Nasopharyngeal CarcinomaPatients with Nasopharyngeal Carcinoma Without Distant Metastases After AJCC/UACC 8th Edition
Jiangxi Provincial Cancer Hospital 325
Testing effectiveness (Phase 2)Looking for participantsNCT06788002
What this trial is testing

LDRT and Chemoimmunotherapy in NPC With Liver Metastasis

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Hunan Cancer Hospital 26
Early research (Phase 1)Study completedNCT00098943
What this trial is testing

NGR-TNF in Treating Patients With Advanced Solid Tumors

Who this might be right for
Colorectal CancerHead and Neck CancerKidney Cancer+1 more
European Organisation for Research and Treatment of Cancer - EORTC 70
Not applicableActive Not RecruitingNCT07248696
What this trial is testing

Tislelizumab Plus Chemotherapy With Response-Adapted Radiotherapy for de Novo Metastatic Nasopharyngeal Carcinoma: A Prospective, Phase II Trial

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Chongqing University Cancer Hospital 32
Next Page